Protein that represses critical checkpoint protein for cellular growth helps drive tumor development

February 13, 2013
Cancerous and healthy breast tissue stained for PRMT6 activity. Credit: 2012 S. Phalke et al.

(Medical Xpress)—One of the hallmarks of cancer is unchecked cellular growth. Fortunately, our cells contain a number of tumor suppressor proteins, including the cell cycle regulator p21, to keep cell growth in check. The protection conferred by p21, however, can be overridden by an overactive histone-modifying enzyme called PRMT6. This protein represses p21 expression, thereby promoting tumor growth and preventing senescence in breast cancer cells, A*STAR scientists have found.

Elevated expression levels of PRMT6 had been reported in a number of cancer types, including breast, cervix, bladder, prostate and lung cancer. However, the protein's role in had not been well established. To elucidate PRMT6's function, cancer biologist Ernesto Guccione and his co-workers at the A*STAR Institute of in Singapore turned to cell lines in which PRMT6 is overexpressed when compared with normal tissue (see image). The researchers used chromatin immunoprecipitation assays, which can determine whether a given protein binds to a specific , and showed that PRMT6 binds directly at the promoter region of the p21 gene.

Depleting PRMT6 led to p21 induction, resulting in growth arrest. Importantly, this effect did not rely on p53, a master tumor suppressor that also interacts with p21. "Our data proves that by targeting PRMT6 we can re-activate the expression of the tumor suppressor p21 in , which would lead to cell cycle arrest and would prevent tumor formation," says Guccione.

Chemists have developed a number of drugs that block PRMT6. However, many of these compounds also inhibit other members of the protein arginine methyltransferase (PRMT) family, resulting in intolerable side effects because of the broad-sweeping nature of these agents on cell physiology. Thus, "it would be very useful to find new inhibitors to specifically target PRMT6 activity," notes Guccione. Researchers in the United States recently discovered two compounds that specifically inhibit PRMT1. Meanwhile, the hunt for selective PRMT6-blockers continues.

Adding further weight to Guccione's team's findings, two research groups working in Europe independently confirmed that the p21 gene is a target of PRMT6 in human bone cancer cell lines. Intriguingly, one group found that p16 is also directly regulated by PRMT6, while the other linked p27 expression to PRMT6 activity. As a follow up, Guccione and his colleagues are now searching for other tumor suppressors affected by PRMT6. "We believe p21 is just one of many targets that are controlled directly by PRMT6," he says.

Explore further: Computer modeling used to study protein involved with cancer, aging and chronic disease

More information: Phalke, S., Mzoughi, S., Bezzi, M., Jennifer, N., Mok, W. C. et al. p53-Independent regulation of p21Waf1/Cip1 expression and senescence by PRMT6. Nucleic Acids Research 40, 9534–9542 (2012). dx.doi.org/10.1093/nar/gks858

Related Stories

Computer modeling used to study protein involved with cancer, aging and chronic disease

April 13, 2011
(PhysOrg.com) -- A new biophysical and biochemical study may lead to better understanding of how structural flexibility controls the interaction of a protein that is closely involved with cancer, aging and other chronic diseases ...

Tissue around tumor holds key to fighting triple negative breast cancer

September 19, 2012
A natural substance found in the surrounding tissue of a tumor may be a promising weapon to stop triple negative breast cancer from metastasizing.

Recommended for you

Cancer-death button gets jammed by gut bacterium

July 27, 2017
Researchers at Michigan Medicine and in China showed that a type of bacterium is associated with the recurrence of colorectal cancer and poor outcomes. They found that Fusobacterium nucleatum in the gut can stop chemotherapy ...

Researchers release first draft of a genome-wide cancer 'dependency map'

July 27, 2017
In one of the largest efforts to build a comprehensive catalog of genetic vulnerabilities in cancer, researchers from the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute have identified more than 760 genes ...

Long-sought mechanism of metastasis is discovered in pancreatic cancer

July 27, 2017
Cells, just like people, have memories. They retain molecular markers that at the beginning of their existence helped guide their development. Cells that become cancerous may be making use of these early memories to power ...

Blocking the back-door that cancer cells use to escape death by radiotherapy

July 27, 2017
A natural healing mechanism of the body may be reducing the efficiency of radiotherapy in breast cancer patients, according to a new study.

Manmade peptides reduce breast cancer's spread

July 27, 2017
Manmade peptides that directly disrupt the inner workings of a gene known to support cancer's spread significantly reduce metastasis in a mouse model of breast cancer, scientists say.

Glowing tumor technology helps surgeons remove hidden cancer cells

July 27, 2017
Surgeons were able to identify and remove a greater number of cancerous nodules from lung cancer patients when combining intraoperative molecular imaging (IMI) - through the use of a contrast agent that makes tumor cells ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.